Zurcher Kantonalbank Zurich Cantonalbank Has $20.18 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 13.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 50,492 shares of the biotechnology company’s stock after acquiring an additional 5,834 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Axon Enterprise were worth $20,177,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. CIBC Asset Management Inc grew its position in Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the period. Foundations Investment Advisors LLC purchased a new stake in Axon Enterprise during the 3rd quarter worth about $221,000. Sequoia Financial Advisors LLC boosted its stake in Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after purchasing an additional 81 shares during the period. Axxcess Wealth Management LLC purchased a new position in Axon Enterprise during the 3rd quarter valued at about $814,000. Finally, Soros Capital Management LLC bought a new stake in shares of Axon Enterprise during the third quarter valued at about $630,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Up 1.9 %

NASDAQ AXON opened at $646.96 on Friday. Axon Enterprise, Inc. has a 1 year low of $224.28 and a 1 year high of $652.22. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business’s 50-day moving average is $483.18 and its 200 day moving average is $376.61. The stock has a market capitalization of $49.33 billion, a PE ratio of 167.17, a PEG ratio of 13.97 and a beta of 0.94.

Analysts Set New Price Targets

Several brokerages have commented on AXON. Robert W. Baird raised their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Craig Hallum lifted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Needham & Company LLC upped their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Barclays lifted their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Finally, Northland Securities upped their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $427.83.

Insider Activity at Axon Enterprise

In other news, Director Julie A. Cullivan sold 900 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total value of $318,177.00. Following the completion of the transaction, the director now owns 3,653 shares in the company, valued at $1,291,445.09. This trade represents a 19.77 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now owns 154,394 shares in the company, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 210,256 shares of company stock worth $87,783,120 over the last quarter. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.